Fenwick represented Belharra Therapeutics on the deal.Belharra Therapeutics, a privately held drug discovery company with a novel photoaffinity-based, non-covalent chemoproteomics platform, announced its multi-year collaboration with Genentech,…
Fenwick represented Belharra Therapeutics on the deal.Belharra Therapeutics, a privately held drug discovery company with a novel photoaffinity-based, non-covalent chemoproteomics platform, announced its multi-year collaboration with Genentech,…